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Abstract
Background: Brain death is strictly defined medically and legally. This diagnosis depends on three
cardinal neurological features: coma, absent brainstem reflexes, and apnea. The diagnosis can only
be made, however, in the absence of intoxication, hypothermia, or certain medical illnesses.
Case presentation: A patient with severe hypoxic-ischemic brain injury met the three cardinal
neurological features of brain death but concurrent profound hypothyroidism precluded the
diagnosis. Our clinical and ethical decisions were further challenged by another facet of this
complex case. Although her brain damage indicated a hopeless prognosis, we could not discontinue
care based on futility because the only known surrogate was mentally retarded and unable to
participate in medical planning.
Conclusion: The presence of certain medical conditions prohibits a diagnosis of brain death,
which is a medicolegal diagnosis of death, not a prediction or forecast of future outcome. While
prognostication is important in deciding to withdraw care, it is not a component in diagnosing brain
death.
Background
Brain death is strictly defined medically and legally [1–5].
We encountered a patient who met the three cardinal neu-
rological features of brain death but the diagnosis was not
possible due to the confounding presence of an underly-
ing medical illness. Further, the only known surrogate was
unable to participate in medical decisions and withdrawal
of care was therefore not immediately possible. We
present this case to teach two critical lessons in patient
care: first, the need for rigorous understanding of the
means by which brain death is diagnosed and second, the
important distinction between a grave prognosis versus
brain death.
Case presentation
A 62-year-old white female collapsed at home after a peri-
od of shortness of breath and "foaming at the mouth."
Her brother, who has Down's syndrome, witnessed these
events. A basic life support team began cardiopulmonary
resuscitation approximately 15 minutes later, noting ab-
sent pulse and respirations. An advanced cardiac life sup-
port team arrived 30 minutes after her collapse.
Evaluation at that time confirmed absent respirations and
pulse with asystole on electrocardiogram. Atropine was
administered followed by epinephrine. The patient's
pulse was restored about 35 minutes after her collapse.
She was intubated and transferred to the emergency de-
partment.
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There, she had pulmonary edema, inferior Q waves, pri-
mary atrioventricular block and a right bundle branch
block with right ventricular strain. Abnormal lab values
included white blood cell count, 15.7; hematocrit, 25.8;
prothrombin time, 22.3; INR, 2.0; PTT, 84.0; CO2, 10;
BUN, 41; creatinine, 1.7; and glucose, 594.
She had a history of hypothyroidism, chronic renal insuf-
ficiency, hypertension, coronary artery disease, non-insu-
lin dependent diabetes mellitus, and psoriatic arthritis.
Her daily medications included aspirin, levothryoxine,
lisinopril, glipizide, simvastatin, omeprazole, lasix, am-
lodipine, prednisone, paroxetine, digoxin, and metopro-
lol.
A neurological consultation four hours after admission re-
vealed an intubated woman who did not respond to nox-
ious stimuli. The pupillary, corneal, oculocephalic, gag
and cough reflexes were absent. Caloric testing was not
performed at this time. Her temperature was 33.1°C.
Her profound hypothermia and history of hypothy-
roidism led us to initiate investigating thyroid functions.
Treatment included re-warming and control of hyperglyc-
emia.
Seven hours after admission, a head CT demonstrated loss
of the gray/white junction, diffuse low density, loss of sul-
ci, and obliterated cisterns suggesting diffuse, severe hy-
poxic injury.
An apnea test conducted 10 hours after admission did not
induce breathing during the 10-minute evaluation. Con-
currently, she had absent pupillary, corneal, gag, cough,
oculocephalic and caloric responses. There was no re-
sponse to deep pain stimulation. At this time she met the
three clinical neurological requirements to diagnose
death by neurological criteria, however, we learned that
her TSH was strikingly elevated at 67.38 uIU/mL (normal
0.4 – 6.00), indicating profound hypothyroidism. Free T4
was low at 0.4 ng/dl (normal 0.8 – 1.8). T3 uptake was
normal (34%). Her last prior TSH level was 2.18 uIU/mL
10 weeks earlier.
From an ethical perspective, we felt justified in offering
the opinion that even if death by neurological criteria was
inappropriate because of hypothyroidism, treatment
could be withdrawn based on her dismal prognosis and
the support of a surrogate decision-maker. Unfortunately,
the only known relative was mentally retarded and inca-
pable of participating in the decision to terminate care for
futility.
Given the profound hypothyroidism confounding a diag-
nosis of brain death, a technetium radionuclide perfusion
study was obtained and revealed absent intracranial
blood flow compatible with brain death. Almost simulta-
neously, remote relatives were contacted who agreed sup-
port should be terminated. This was done and the patient
expired.
Conclusions
This interesting case taught us two clinical lessons. First,
the importance of recognizing that certain medical illness-
es, like severe hypothyroidism, prevent diagnosing death
by neurological criteria, even when the three cardinal neu-
rological features exist. Second, a hopeless prognosis may
still allow for withdrawal of care but only when a surro-
gate can participate in clinical decisions and agree with
the proposal.
Brain death is defined as the irreversible cessation of func-
tion of the entire brain with three specific criteria: 1) co-
ma, 2) absent brainstem reflexes and 3) apnea. In
addition to these clinical criteria, there are important pre-
requisites: 1) no drug intoxication or poisoning, 2) core
temperature greater than 32 degrees Celsius, 3) clinical or
neuroimaging evidence of acute central nervous system
catastrophe and 4) absence of confounding medical con-
ditions such as severe electrolyte, acid-base, or endocrine
disturbances [5].
Our patient had a severe hypoxic-ischemic injury support-
ed by the abnormal head CT. While she satisfied the car-
dinal neurological aspects for diagnosing brain death, the
laboratory evidence indicated the presence of a confound-
ing medical illness, thus precluding satisfaction of the
necessary brain death prerequisites. Her profound hy-
pothyroidism had a major impact on our clinical and eth-
ical decisions.
The role hypothyroidism played in her clinical state may
be debatable. We considered whether the elevated TSH
might have simply "leaked" from an ischemic pituitary
gland but TSH levels are not usually increased in brain
dead patients [6]. Additionally, the patient was awake pri-
or to her collapse and not overtly impaired until after her
cardiac arrest suggesting against a substantial contribution
from hypothyroidism. With the severe structural brain
damage from her hypoxic-ischemic event, we recognized
she had little chance of meaningful recovery [7]. Her poor
prognosis, therefore, was seemingly unrelated to hypothy-
roidism. However, life-threatening hypothyroidism can
manifest as hypothermia and depressed neurological
function, in essence exaggerating neurological impair-
ment. We, therefore, felt unable to meet the strict exclu-
sionary aspects to diagnose death by neurological criteria.
Our reluctance to declare brain death due to hypothy-
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tium radionuclide scan. Confirmatory tests are optional in
most countries, including the United States [8,9]. In the
United Kingdom, the concept of brainstem death pre-
cludes examination of the cortex and subcortex with EEG
and other ancillary tests [10]. Confirmatory testing is
most commonly needed when specific neurological eval-
uations cannot be performed, (e.g., orbital trauma may
frustrate attempts to evaluate pupillary function or hypo-
tension may preclude an adequate apnea test). Generally
accepted confirmatory tests include electroencephalogra-
phy (EEG) or a conventional angiogram [5], although
standardized guidelines have not been published. In the
intensive care unit it is often difficult to perform an EEG
of sufficient sensitivity due to the presence of artifact,
while the invasive nature of an angiogram can be limiting.
Alternatively, the American Academy of Neurology has ac-
cepted the use of Doppler ultrasound after a comprehen-
sive review of its utility indicated it was 94% sensitive and
100% specific in the diagnosis of brain death [11]. Less ev-
idence exists to support the use of other miscellaneous
tests including brain perfusion studies, such as the one we
utilized, although the sensitivity of the technetium radio-
nuclide scans has been reported to be 94% with a specifi-
city of 100% [12].
The family's decision to withdraw care removed the bur-
den of applying the results of the perfusion scan. We
think, however, that lacking family input, the absent cere-
bral blood flow would have persuaded us to diagnose
brain death.
This clinical interaction demonstrates some of the medi-
cal and ethical challenges in the diagnosis of brain death.
Brain death is synonymous with death and not a prognos-
tication of future outcome. While a patient's prognosis
plays an important role in decisions about withdrawal of
care, prognosis does not play a role in the medico-legal
realm of declaring brain death. In the setting of a poor
prognosis, a capable surrogate can support a plan to ter-
minate care for futility even when the brain death diagno-
sis is thwarted. Clinicians should not allow a dismal
prognosis to introduce bias into declaring brain death but
should strictly adhere to the clear medicolegal criteria.
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